Nucleoporin phosphorylation triggered by the encephalomyocarditis virus leader protein is mediated by mitogen-activated protein kinases

Journal of Virology

Volumn 84, Issue 24, 2010, Pages 12538-12548

  Porter, Frederick W ^a,b   Brown, Bradley ^a   Palmenberg, Ann C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Novartis Vaccines and Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NUCLEOPORIN; PHOSPHOPEPTIDE; PHOSPHOSERINE; PHOSPHOTHREONINE; RECOMBINANT PROTEIN; VIRUS PROTEIN; ZINC FINGER PROTEIN;

ARTICLE; CONSENSUS; ENCEPHALOMYOCARDITIS VIRUS; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT;

BLOTTING, WESTERN; BUTADIENES; CARDIOVIRUS INFECTIONS; ENCEPHALOMYOCARDITIS VIRUS; ENZYME INHIBITORS; HELA CELLS; HUMANS; IMIDAZOLES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; NUCLEAR PORE COMPLEX PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPEPTIDES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PYRIDINES; VIRAL PROTEINS;

CARDIOVIRUS; ENCEPHALOMYOCARDITIS VIRUS;

EID: 78649423065     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01484-09     Document Type: Article

References (52)

1. Aminev, A. G., S. P. Amineva, and A. C. Palmenberg. 2003. Encephalomyocarditis viral protein 2A localizes to nucleoli and inhibits cap-dependent mRNA translation. Virus Res. 95:45-57.
2. Aminev, A. G., S. P. Amineva, and A. C. Palmenberg. 2003. Encephalomyocarditis virus (EMCV) proteins 2A and 3BCD localize to nuclei and inhibit cellular mRNA transcription but not rRNA transcription. Virus Res. 95:59-73.
3. Amineva, S. P., A. G. Aminev, A. C. Palmenberg, and J. E. Gern. 2004. Rhinovirus 3C protease precursors 3CD and 3CD′ localize to the nuclei of infected cells. J. Gen. Virol. 85:2969-2979.
4. Bardina, M. V., P. Lidsky, E. V. Sheval, K. V. Fominykh, F. J. van Kuppeveld, V. Y. Polyakov, and V. Agol. 2009. Mengovirus-induced rearrangements of the nuclear pore complex: hijacking cellular phosphorylation machinery. J. Virol. 83:3150-3161.
5. Bayliss, R., T. Littlewood, and M. Stewart. 2000. Structural basis for the interaction between FxFG nucleoporin repeats and importin-β in nuclear trafficking. Cell 102:99-108.
6. Carmo-Fonseca, M., H. Kern, and E. C. Hurt. 1991. Human nucleoporin p62 and the essential yeast nuclear pore protein NSP1 show sequence homology and a similar domain organization. Eur. J. Cell Biol. 55:17-30.
7. Chen, Y., Y. Xu, Q. Bao, Y. Xing, Z. Li, Z. Lin, J. B. Stock, P. D. Jeffrey, and Y. Shi. 2007. Structural and biochemical insights into the regulation of protein phosphatase 2A by small t antigen of SV40. Nat. Struct. Mol. Biol. 14:527-534.
8. Clark, M. E., T. Hammerle, E. Wimmer, and A. Dasgupta. 1991. Poliovirus protease 3C converts an active form of transcription factor IIIC to an inactive form: a mechanism for inhibition of host cell polymerase III transcription by poliovirus. EMBO J. 10:2941-2948.
9. Cornilescu, C. C., F. W. Porter, Q. Zhao, A. C. Palmenberg, and J. L. Markley. 2008. NMR structure of the mengovirus leader protein zinc-finger domain. FEBS Lett. 582:896-900.
10. Delhaye, S., V. van Pesch, and T. Michiels. 2004. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J. Virol. 78:4357-4362. (Pubitemid 38437239)
11. Dvorak, C. M. T., D. J. Hall, M. Hill, M. Riddle, A. Pranter, J. Dillman, M. Deibel, and A. C. Palmenberg. 2001. Leader protein of encephalomyocarditis virus binds zinc, is phosphorylated during viral infection and affects the efficiency of genome translation. Virology 290:261-271.
12. Eblen, S. T., N. V. Kumar, K. Shah, M. J. Henderson, C. K. Watts, K. M. Shokat, and M. J. Weber. 2003. Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs. J. Biol. Chem. 278:14926-14935.
13. Egger, D., N. Teterina, E. Ehrenfeld, and K. Bienz. 2000. Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J. Virol. 74:6570-6580. (Pubitemid 30429826)
14. Favreau, C., H. J. Worman, R. W. Wozniak, T. Frappier, and J. C. Courvalin. 1996. Cell cycle-dependent phosphorylation of nucleoporins and nuclear pore membrane protein Gp210. Biochemistry 35:8035-8044.
15. Garrington, T. P., and G. L. Johnson. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:211-218.
16. Gradi, A., Y. V. Svitkin, H. Imataka, and N. Sonenberg. 1998. Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4FI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc. Natl. Acad. Sci. U. S. A. 15:11089-11094.
17. Groppo, R., and A. Palmenberg. 2007. Cardiovirus 2A protein associates with 40S but not 80S ribosome subunits during infection. J. Virol. 81:13067-13074. (Pubitemid 350156945)
18. Gustin, K. E., and P. Sarnow. 2001. Effects of poliovirus infection on nucleocytoplasmic trafficking and nuclear pore complex composition. EMBO J. 20:240-249.
19. Haghighat, A., Y. Svitkin, I. Novoa, E. Kuechler, T. Skern, and N. Sonenberg. 1996. The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. J. Virol. 70:8444-8450. (Pubitemid 26378421)
20. Hahn, H., and A. C. Palmenberg. 1995. Encephalomyocarditis viruses with short poly(C) tracts are more virulent than their Mengo virus counterparts. J. Virol. 69:2697-2699.
21. Hirasawa, K., A. Kim, H. S. Han, J. Han, H. S. Jun, and J. W. Yoon. 2003. Effect of p38 mitogen-activated protein kinase on the replication of encephalomyocarditis virus. J. Virol. 77:5649-5656.
22. Huber, M., K. A. Watson, H. C. Selinka, C. M. Carthy, K. Klingel, B. McManus, and R. Kandolf. 1999. Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J. Virol. 73:3587-3594. (Pubitemid 29189798)
23. Junttila, M. R., S.-P. Li, and J. Westermarck. 2008. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J. 22:954-965. (Pubitemid 351519953)
24. Keyse, S. M. 2000. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12:186-192.
25. Kundu, P., S. Raychaudhuri, W. Tsai, and A. Dasgupta. 2005. Shutoff of RNA polymerase II transcription by poliovirus involves 3C protease-mediated cleavage of the TATA-binding protein at an alternative site: incomplete shutoff of transcription interferes with efficient viral replication. J. Virol. 79:9702-9713. (Pubitemid 41022313)
26. Kyriakis, J. M., and J. Avruch. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807-869.
27. Lee, T., A. N. Hoofnagle, Y. Kabuyama, J. Stroud, X. Min, E. J. Goldsmith, L. Chen, K. A. Resing, and N. G. Ahn. 2004. Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. Mol. Cell 14:43-55.
28. Lee, W.-M., C. Kiesner, T. Pappas, I. Lee, K. Grindle, T. Jartti, B. Jakiela, R. F. Lemanske, P. A. Shult, and J. E. Gern. 2007. A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLos ONE 2:e966.
29. Lidsky, P. L., S. Hato, M. V. Bardina, A. G. Aminev, A. C. Palmenberg, E. V. Sheval, V. Y. Polyakov, F. J. van Kuppeveld, and V. Agol. 2006. Nucleocytoplasmic traffic disorder induced by cardioviruses. J. Virol. 80:2705-2717.
30. Lu, D., H. Yang, and M. K. Raizada. 1998. Involvement of p62 nucleoporin in angiotensin II-induced nuclear translocation of STAT3 in brain neurons. J. Neurosci. 18:1329-1336.
31. Macaulay, C., E. Meier, and D. J. Forbes. 1995. Differential mitotic phosphorylation of proteins of the nuclear pore complex. J. Biol. Chem. 270:254-262.
32. Mahoney, C. W., N. Nakanishi, and M. Ohashi. 1996. Phosphoamino acid analysis by semidry electrophoresis on cellulose thin-layer plates using the Pharmacia/LKB Multiphor or Atto flatbed apparatus. Anal. Biochem. 238:96-98.
33. Meijer, L., A. Borgne, O. Mulner, J. P. Chong, J. J. Blow, N. Inagaki, M. Inagaki, J. G. Delcros, and J. P. Moulinoux. 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243:527-536.
34. Miller, M. W., M. R. Caracciolo, W. K. Berlin, and J. A. Hanover. 1999. Phosphorylation and glycosylation of nucleoporins. Arch. Biochem. Biophys. 367:51-60.
35. Mosammaparast, N., and L. F. Pemberton. 2004. Karyopherins: from nuclear-transport mediators to nuclear-function regulators. Trends Cell Biol. 14:547-556.
36. Neduva, V., R. Linding, I. Su-Angrand, A. Stark, F. de Masi, T. J. Gibson, J. Lewis, L. Serrano, and R. B. Russell. 2005. Systematic discovery of new recognition peptides mediating protein interaction networks. PLoS Biol. 3:2090-2099.
37. Ohno, M., A. Segref, A. Bachi, M. Wilm, and I. W. Mattaj. 2000. PHAX, a mediator of U snRNA nuclear export whose activity is regulated by phosphorylation. Cell 101:187-198.
38. Palmenberg, A. C. 1990. Proteolytic processing of picornaviral polyprotein. Annu. Rev. Microbiol. 44:603-623.
39. Park, N., P. Katikaneni, T. Skern, and K. E. Gustin. 2008. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J. Virol. 82:1647-1655.
40. Porter, F. W., Y. A. Bochkov, A. J. Albee, C. Wiese, and A. C. Palmenberg. 2006. A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport. Proc. Natl. Acad. Sci. U. S. A. 103:12417-12422.
41. Porter, F. W., and A. C. Palmenberg. 2009. Leader-induced phosphorylation of nucleoporins correlates with nuclear trafficking inhibition of cardioviruses. J. Virol. 83:1941-1951.
42. Racaniello, V. R. 2001. Picornaviridae: the viruses and their replication, p. 685-722. In D. M. Knipe et al. (ed.), Fields virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, PA.
43. Romanova, L., P. Lidsky, M. Kolesnikova, K. V. Fominykh, A. P. Gmyl, E. V. Sheval, S. V. Hato, F. J. van Kuppeveld, and V. Agol. 2009. Antiapoptotic activity of the cardiovirus leader protein, a viral "security" protein. J. Virol. 83:7273-7284.
44. Roux, P. P., and J. Blenis. 2004. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68:320-344.
45. Sheridan, D. L., Y. Kong, S. A. Parker, K. N. Dalby, and B. E. Turk. 2008. Substrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifs. J. Biol. Chem. 283:19511-19520.
46. Songyang, Z., K. P. Lu, Y. T. Kwon, L. H. Tsai, O. Filhol, C. Cochet, D. A. Brickey, T. R. Soderling, C. Bartleson, D. J. Graves, A. J. DeMaggio, M. F. Hoekstra, J. Blenis, T. Hunter, and L. C. Cantley. 1996. A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell. Biol. 16:6486-6493.
47. Stewart, M., R. P. Baker, R. Bayless, L. Clayton, R. P. Grant, T. Littlewood, and Y. Matsuura. 2001. Molecular mechanism of translocation through nuclear pore complexes during nuclear protein import. FEBS Lett. 498:145-149. (Pubitemid 32539192)
48. van Pesch, V., O. van Eyll, and T. Michiels. 2001. The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J. Virol. 75:7811-7817.
49. Vesely, J., L. Havlicek, M. Strnad, J. J. Blow, A. Donella-Deana, L. Pinna, D. S. Letham, J.-Y. Kato, L. Detivaud, and C. Leclerc. 1994. Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224:771-786.
50. pro. Virology 239:176-185.
51. Zoll, J., J. M. D. Galama, F. J. M. van Kuppeveld, and W. J. G. Melchers. 1996. Mengovirus leader is involved in the inhibition of host cell protein synthesis. J. Virol. 70:4948-4958.
52. Zoll, J., W. J. Melchers, J. M. Galama, and F. J. van Kuppeveld. 2002. The mengovirus leader protein suppresses alpha/beta interferon production by inhibition of the iron/ferritin-mediated activation of NF-kappa B. J. Virol. 76:9664-9672. (Pubitemid 35006507)